How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

SLE Faculty Panel: Q&A at RheumNow Live! 2024

RheumNow

D. Karp, J. Michelle Kahlenberg, A. Fava

Health Disparities in SLE

Hospital for Special Surgery

J. Yazdany

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

Update in the Understanding and Management of Lupus

ARTHROS

M. Petri

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

CHEST 2022 Coverage

T. Kulkarni

Dermatologic Manifestations in Rheumatic Diseases

Saakshi Khattri

Defining the Molecular Natural History of Early and Progressive Pulm…

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

N. Banovich

2022 Updates on the Management of Lupus Nephritis

West Virginia State Rheumatology Society

M. Petri

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

S. Metyas

Challenges in ILD: Prediction With or Without Big Data

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

T. Fingerlin

Ever-Evolving Lupus Case & Cytopenias in SLE

Cleveland Clinic Rheumatology

E. Littlejohn

EADV 2024 Insights: Eosinophilic Fasciitis

EADV 2024 Insights

F. Rongioletti

Hurdles on the Way to Disease Modification in Lupus

ARTHROS

M. Petri

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

Toby Maher

CAR-T Cells Enter the Treatment Arena of IMIDS

Cleveland Clinic Rheumatology

W. Rigby

Panel Discussion Chaired by Dr. Weichart on Big Data and How to Move…

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

T. Weichhart

SLE Management

Arthros .

M. Petri

Bullous Pemphigoid Updates (2024)

NYU Langone

P. Adotama